Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis.
about
Clinical management of infections caused by multidrug-resistant EnterobacteriaceaePolyclonal spread and outbreaks with ESBL positive gentamicin resistant Klebsiella spp. in the region Kennemerland, The Netherlands.No nosocomial transmission under standard hygiene precautions in short term contact patients in case of an unexpected ESBL or Q&A E. coli positive patient: a one-year prospective cohort study within three regional hospitalsExtended-spectrum beta-lactamase-producing bacteria are not detected in supragingival plaque samples from human fecal carriers of ESBL-producing Enterobacteriaceae.Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae--a case-control study in a low prevalence country.Impact of extended-spectrum β-lactamase production on treatment outcomes of acute pyelonephritis caused by escherichia coli in patients without health care-associated risk factors.Fosfomycin versus meropenem in bacteraemic urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli (FOREST): study protocol for an investigator-driven randomised controlled trial.Use of an Enrichment Broth Improves Detection of Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae in Clinical Stool Samples.Rectal Carriage of Extended-Spectrum-Beta-Lactamase-Producing Enterobacteriaceae in Hospitalized Patients: Selective Preenrichment Increases Yield of Screening.Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremiaIntestinal Carriage of Carbapenemase-Producing Organisms: Current Status of Surveillance MethodsPrevalence, risk factors and molecular epidemiology of highly resistant gram negative rods in hospitalized patients in the Dutch region Kennemerland.Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria.Sepsis Caused by Extended-Spectrum Beta-Lactamase (ESBL)-Positive K. pneumoniae and E. coli: Comparison of Severity of Sepsis, Delay of Anti-Infective Therapy and ESBL Genotype.The health and economic burden of bloodstream infections caused by antimicrobial-susceptible and non-susceptible Enterobacteriaceae and Staphylococcus aureus in European hospitals, 2010 and 2011: a multicentre retrospective cohort study.E. coli bacteremia in comparison to K. pneumoniae bacteremia: influence of pathogen species and ESBL production on 7-day mortality.Whole-Genome Multilocus Sequence Typing of Extended-Spectrum-Beta-Lactamase-Producing EnterobacteriaceaeA multidisciplinary intervention to reduce infections of ESBL- and AmpC-producing, gram-negative bacteria at a University Hospital.Exposure assessment of extended-spectrum beta-lactamases/AmpC beta-lactamases-producing Escherichia coli in meat in Denmark.Mortality and molecular epidemiology associated with extended-spectrum β-lactamase production in Escherichia coli from bloodstream infection.Detecting risk and predicting patient mortality in patients with extended-spectrum β-lactamase-producing Enterobacteriaceae bloodstream infections.Impact of antimicrobial multidrug resistance on inpatient care cost: an evaluation of the evidence.Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing Enterobacteriaceae.Deaths attributable to carbapenem-resistant Enterobacteriaceae infections.Improved treatment of multidrug-resistant bacterial infections: utility of clinical studies.Colonization and infection with extended-spectrum beta-lactamase producing Enterobacteriaceae in patients with malignancy.Contact precautions for preventing nosocomial transmission of ESBL-producing Escherichia coli - a point/counterpoint review.Clinical Outcomes and Healthcare Utilization Related to Multidrug-Resistant Gram-Negative Infections in Community Hospitals.Infections due to Carbapenem Resistant Enterobacteriaceae among Saudi Arabian Hospitalized Patients: A Matched Case-Control Study.Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?Frequency, associated factors and outcome of multi-drug-resistant intensive care unit-acquired pneumonia among patients colonized with extended-spectrum β-lactamase-producing Enterobacteriaceae.Prospective, randomized, double-blind, Phase 2 dose-ranging study comparing efficacy and safety of imipenem/cilastatin plus relebactam with imipenem/cilastatin alone in patients with complicated urinary tract infections.Importance of pre-enrichment for detection of third-generation cephalosporin-resistant Enterobacteriaceae (3GCREB) from rectal swabs.Escherichia coli and Klebsiella pneumoniae bacteremia in patients with neutropenic fever: factors associated with extended-spectrum β-lactamase production and its impact on outcome.Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-β-lactamase-producing Enterobacteriaceae.ESBL/AmpC-producing Enterobacteriaceae in households with children of preschool age: prevalence, risk factors and co-carriage.Colonization with third-generation cephalosporin-resistant Enterobacteriaceae on hospital admission: prevalence and risk factors.Detection of Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Market-Ready Chickens in Zambia.Risk factors, outcome and impact of empirical antimicrobial treatment in extended-spectrum β-lactamase-producing Escherichia coli bacteraemia.Scientific Opinion on the public health hazards to be covered by inspection of meat (bovine animals)
P2860
Q28246841-D9EBD86F-4891-4C7E-9B9F-0F5CE102F778Q33817429-BA453B24-6433-4547-A653-C0B485158D28Q33837065-EBA825A6-8ECC-4CC3-93C0-80585C0D3CDAQ34079113-F360213C-137F-473B-BCDC-8F7F00CF6ED2Q34920553-D8B6D990-6420-46C8-8493-D89C2FD136EDQ35168939-ED213F73-B105-4A88-95A1-C05F9B1DC7D4Q35278325-C833654F-DEB4-4AB8-AEB9-33033F9F0B3FQ35853128-A6520B6A-6B03-4EC8-9986-5F769D2C2A2EQ35868674-ED4060D2-0E35-40D7-8038-2566E7511A3DQ35960721-A3A3383F-0AFA-47B4-A4C1-75B6003F71A6Q36631019-3911F4E5-50CB-4C38-8E8A-D8E3BFBFB70EQ36667941-9BC07B63-C043-43A6-9580-E586A8B6BBB6Q36969726-9D87BC66-A2D9-4FD6-AB13-57AD7C240766Q37114901-06A9C181-A8CC-4A26-8802-F250938B8B33Q37205523-D1CDB534-EF42-4686-8B4D-1423A326B330Q37350084-392C867B-1B37-4E63-9FB0-DC05B9F45E3EQ37434290-DCAAE7A1-1D54-4775-ACF4-29BBBA4EE82DQ37510069-B0E20030-CAEA-400D-B5E7-5B1ABBA6D3D2Q37564145-4C6ACE31-F516-406A-94A4-91B42D4E4350Q37644572-FADE18B5-CD52-4E95-B35D-F9E44335872FQ38048860-35A44699-92D6-4BD1-95FE-A21A4CD0F8AEQ38086340-8156DCCF-CC39-4108-BB66-80D5BB009545Q38165138-ADC167A7-FF06-47F7-9976-93A861E3D3D1Q38222776-4E64885D-75FB-4702-82C7-88060D28A2E5Q38232197-0F8DA440-5823-4785-A866-7FCB1265F80FQ38665505-9265B857-C878-4D50-9DD4-401A0A669E71Q39221599-DDD402E6-172D-40DF-8D7D-7435CFE31F32Q39304889-9836E11A-E921-4ABF-A64B-A3DCC076595BQ39796166-2FBF9E2A-639E-4E75-B0FB-8DB171BB0512Q40119449-A4A11917-0FAB-4772-8A4A-E097DBD7A972Q40174829-5CAD4ACB-0585-40EE-B6DB-B45EFC706815Q40187323-A1AFC2BA-7812-401B-BD56-A7273C423995Q40225514-8B151395-D7AD-4A64-A2D4-285F329BCA34Q40267702-46596061-CC42-4557-8972-5053D270DD21Q40381772-73C4D7D0-59A9-465B-BB9C-61417FC7CB3FQ40476043-E6AD4B5A-242A-4064-8328-12F283D95366Q40694112-E2A0194C-5AF4-4EA3-8039-A4C316ACDCEEQ40845102-8248F6F6-0B62-4A95-844A-B6BF2CE6A0F1Q41750938-6577EAA3-DA0A-4BE0-981E-14E2A7533F77Q47153429-C563C499-DD0B-4920-81D2-4268CE1CC23B
P2860
Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum β-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Effects of confounders and int ...... ient outcome: a meta-analysis.
@en
Effects of confounders and int ...... ient outcome: a meta-analysis.
@nl
type
label
Effects of confounders and int ...... ient outcome: a meta-analysis.
@en
Effects of confounders and int ...... ient outcome: a meta-analysis.
@nl
prefLabel
Effects of confounders and int ...... ient outcome: a meta-analysis.
@en
Effects of confounders and int ...... ient outcome: a meta-analysis.
@nl
P2860
P356
P1476
Effects of confounders and int ...... ient outcome: a meta-analysis.
@en
P2093
Heidi S M Ammerlaan
Marc J M Bonten
P2860
P304
P356
10.1093/JAC/DKS065
P407
P50
P577
2012-03-05T00:00:00Z